Conmed Corp
CNMD40.770USD
+0.600+1.49%
收盘 12/26, 16:00（美东）报价延迟15分钟
1.26B总市值
19.71市盈率 TTM
关于 Conmed Corp 公司
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Conmed Corp简介
公司代码CNMD
公司名称Conmed Corp
上市日期Jul 23, 1987
CEOBeyer (Patrick J)
员工数量3900
证券类型Ordinary Share
年结日Jul 23
公司地址11311 Concept Boulevard
城市LARGO
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编33773
电话17272142974
网址https://www.conmed.com/
公司代码CNMD
上市日期Jul 23, 1987
CEOBeyer (Patrick J)
Conmed Corp公司高管
名称
名称/职务
职务
持股
持股变动
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.13K
+18.20%
Mr. Kim Kelderman
Mr. Kim Kelderman
Independent Director
Independent Director
--
--
Mr. Richard Glaze
Mr. Richard Glaze
Chief Information Officer
Chief Information Officer
--
-100.00%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%
地区USD
名称
营收
占比
United States
190.61M
55.68%
Europe & Middle East & Africa
63.92M
18.67%
Asia Pacific
42.07M
12.29%
Americas (excluding the United States)
31.88M
9.31%
业务
地区
业务USD
名称
营收
占比
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%
股东统计
更新时间: 11月30日 周日
更新时间: 11月30日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.90%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.04%
Fuller & Thaler Asset Management Inc.
5.60%
Westwood Management Corp. (Texas)
4.29%
其他
55.53%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.90%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.04%
Fuller & Thaler Asset Management Inc.
5.60%
Westwood Management Corp. (Texas)
4.29%
其他
55.53%
股东类型
持股股东
占比
Investment Advisor
55.01%
Investment Advisor/Hedge Fund
46.65%
Hedge Fund
7.01%
Research Firm
2.89%
Pension Fund
1.93%
Bank and Trust
0.68%
Individual Investor
0.59%
Sovereign Wealth Fund
0.06%
Insurance Company
0.04%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
638
36.30M
136.51%
+226.00
2025Q3
655
36.31M
137.32%
-1.03M
2025Q2
649
37.27M
138.33%
-832.15K
2025Q1
642
38.16M
137.89%
-4.49M
2024Q4
628
38.56M
133.23%
+1.56M
2024Q3
620
37.00M
134.64%
-1.79M
2024Q2
640
38.79M
129.72%
+1.14M
2024Q1
637
37.49M
133.32%
-3.56M
2023Q4
623
39.15M
131.18%
+747.69K
2023Q3
604
38.42M
132.14%
+127.38K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
4.43M
14.3%
-133.34K
-2.92%
Jun 30, 2025
The Vanguard Group, Inc.
3.54M
11.44%
+42.41K
+1.21%
Jun 30, 2025
EARNEST Partners, LLC
2.83M
9.14%
+30.22K
+1.08%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.74M
5.62%
+566.60K
+48.26%
Jun 30, 2025
Westwood Management Corp. (Texas)
1.24M
4%
-484.00
-0.04%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.08M
3.5%
+184.21K
+20.50%
Jun 30, 2025
State Street Investment Management (US)
1.29M
4.18%
-8.83K
-0.68%
Jun 30, 2025
Managed Account Advisors LLC
1.38M
4.47%
+103.77K
+8.11%
Jun 30, 2025
Silvercrest Asset Management Group LLC
851.95K
2.75%
-183.66K
-17.73%
Jun 30, 2025
Capital Research Global Investors
1.68M
5.41%
+2.76K
+0.16%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
State Street SPDR S&P Health Care Equipment ETF
1.48%
ROBO Global Healthcare Technology & Innovation ETF
1.05%
Invesco S&P SmallCap Health Care ETF
0.83%
Harbor Human Capital Factor US Small Cap ETF
0.56%
First Trust Small Cap Value AlphaDEX Fund
0.49%
VictoryShares Small Cap Free Cash Flow ETF
0.36%
WisdomTree US SmallCap Quality Dividend Growth
0.24%
First Trust Small Cap Core Alphadex Fund
0.24%
Lattice Hartford Multifactor Small Cap ETF
0.23%
Franklin US Small Cap Multifactor Index ETF
0.2%
查看更多
State Street SPDR S&P Health Care Equipment ETF
占比1.48%
ROBO Global Healthcare Technology & Innovation ETF
占比1.05%
Invesco S&P SmallCap Health Care ETF
占比0.83%
Harbor Human Capital Factor US Small Cap ETF
占比0.56%
First Trust Small Cap Value AlphaDEX Fund
占比0.49%
VictoryShares Small Cap Free Cash Flow ETF
占比0.36%
WisdomTree US SmallCap Quality Dividend Growth
占比0.24%
First Trust Small Cap Core Alphadex Fund
占比0.24%
Lattice Hartford Multifactor Small Cap ETF
占比0.23%
Franklin US Small Cap Multifactor Index ETF
占比0.2%
分红派息
近5年累计派现
119.19M
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Aug 08, 2025
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 03, 2025 going ex on Sep 15, 2025
Sep 15, 2025
Oct 03, 2025
Sep 15, 2025
May 21, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 03, 2025 going ex on Jun 13, 2025
Jun 13, 2025
Jul 03, 2025
Jun 13, 2025
Feb 25, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 04, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 04, 2025
Mar 14, 2025
Dec 10, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 03, 2025 going ex on Dec 20, 2024
Dec 20, 2024
Jan 03, 2025
Dec 20, 2024
Aug 09, 2024
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 04, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 04, 2024
Sep 16, 2024
May 22, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 26, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Dec 05, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2024 going ex on Dec 15, 2023
Dec 18, 2023
Jan 05, 2024
Dec 15, 2023
Aug 10, 2023
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 05, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 05, 2023
Sep 14, 2023
May 24, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 05, 2023
Jun 14, 2023
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Conmed Corp的前五大股东是谁？
Conmed Corp 的前五大股东如下：
BlackRock Institutional Trust Company, N.A.持有股份：4.43M，占总股份比例：14.30%。
The Vanguard Group, Inc.持有股份：3.54M，占总股份比例：11.44%。
EARNEST Partners, LLC持有股份：2.83M，占总股份比例：9.14%。
Fuller & Thaler Asset Management Inc.持有股份：1.74M，占总股份比例：5.62%。
Westwood Management Corp. (Texas)持有股份：1.24M，占总股份比例：4.00%。
BlackRock Institutional Trust Company, N.A.持有股份：4.43M，占总股份比例：14.30%。
The Vanguard Group, Inc.持有股份：3.54M，占总股份比例：11.44%。
EARNEST Partners, LLC持有股份：2.83M，占总股份比例：9.14%。
Fuller & Thaler Asset Management Inc.持有股份：1.74M，占总股份比例：5.62%。
Westwood Management Corp. (Texas)持有股份：1.24M，占总股份比例：4.00%。
Conmed Corp的前三大股东类型是什么？
Conmed Corp 的前三大股东类型分别是：
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
EARNEST Partners, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
EARNEST Partners, LLC
有多少机构持有Conmed Corp(CNMD)的股份？
截至2025Q4，共有638家机构持有Conmed Corp的股份，合计持有的股份价值约为36.30M，占公司总股份的136.51%。与2025Q3相比，机构持股有所增加，增幅为-0.81%。
哪个业务部门对Conmed Corp的收入贡献最大？
在FY2025Q2，General Surgery业务部门对Conmed Corp的收入贡献最大，创收201.61M，占总收入的58.89%。
